These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 34697065)
1. Fusion of the Paired Box 3 ( Panagopoulos I; Gorunova L; Andersen K; Lund-Iversen M; Tafjord S; Micci F; Heim S Cancer Genomics Proteomics; 2021; 18(6):723-734. PubMed ID: 34697065 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic and Molecular Features of a Series of 41 Biphenotypic Sinonasal Sarcomas Expanding Their Molecular Spectrum. Le Loarer F; Laffont S; Lesluyes T; Tirode F; Antonescu C; Baglin AC; Delespaul L; Soubeyran I; Hostein I; Pérot G; Chibon F; Baud J; Le Guellec S; Karanian M; Costes-Martineau V; Castain C; Eimer S; Le Bail B; Wassef M; Coindre JM Am J Surg Pathol; 2019 Jun; 43(6):747-754. PubMed ID: 30829729 [TBL] [Abstract][Full Text] [Related]
3. OLIG2 is a novel immunohistochemical marker associated with the presence of PAX3/7-FOXO1 translocation in rhabdomyosarcomas. Kaleta M; Wakulińska A; Karkucińska-Więckowska A; Dembowska-Bagińska B; Grajkowska W; Pronicki M; Łastowska M Diagn Pathol; 2019 Sep; 14(1):103. PubMed ID: 31493794 [TBL] [Abstract][Full Text] [Related]
4. PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma. Pandey PR; Chatterjee B; Olanich ME; Khan J; Miettinen MM; Hewitt SM; Barr FG J Pathol; 2017 Apr; 241(5):626-637. PubMed ID: 28138962 [TBL] [Abstract][Full Text] [Related]
5. The PAX3-FOXO1 fusion protein present in rhabdomyosarcoma interferes with normal FOXO activity and the TGF-β pathway. Schmitt-Ney M; Camussi G PLoS One; 2015; 10(3):e0121474. PubMed ID: 25806826 [TBL] [Abstract][Full Text] [Related]
12. Biphenotypic sinonasal sarcoma with PAX3::MAML3 fusion transforming into high-grade rhabdomyosarcoma: report of an emerging rare phenomenon. Meyer A; Klubíčková N; Mosaieby E; Grossmann P; Kalmykova A; Koshyk O; Michal M Virchows Arch; 2023 Apr; 482(4):777-782. PubMed ID: 36719455 [TBL] [Abstract][Full Text] [Related]
13. A study of alveolar rhabdomyosarcoma copy number alterations by single nucleotide polymorphism analysis. Lynn M; Shah N; Conroy J; Ennis S; Morris T; Betts D; O'Sullivan M Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):213-21. PubMed ID: 24614150 [TBL] [Abstract][Full Text] [Related]
14. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Barr FG Oncogene; 2001 Sep; 20(40):5736-46. PubMed ID: 11607823 [TBL] [Abstract][Full Text] [Related]
15. Pax3 loss of function delays tumour progression in kRAS-induced zebrafish rhabdomyosarcoma models. Kahsay A; Rodriguez-Marquez E; López-Pérez A; Hörnblad A; von Hofsten J Sci Rep; 2022 Oct; 12(1):17149. PubMed ID: 36229514 [TBL] [Abstract][Full Text] [Related]
16. [Expression of fusion gene PAX3/PAX7-FKHR and chromosomal aberration in rhabdomyosarcoma]. Gao H; Ou YL; Zhang KR; Zhang ZB; Wang WL Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):42-7. PubMed ID: 17285543 [TBL] [Abstract][Full Text] [Related]
17. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3. Fredericks WJ; Galili N; Mukhopadhyay S; Rovera G; Bennicelli J; Barr FG; Rauscher FJ Mol Cell Biol; 1995 Mar; 15(3):1522-35. PubMed ID: 7862145 [TBL] [Abstract][Full Text] [Related]
18. JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells. Walters ZS; Villarejo-Balcells B; Olmos D; Buist TW; Missiaglia E; Allen R; Al-Lazikani B; Garrett MD; Blagg J; Shipley J Oncogene; 2014 Feb; 33(9):1148-57. PubMed ID: 23435416 [TBL] [Abstract][Full Text] [Related]